Neo Ivy Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,948
| Closed | -$1.23M | – | 405 |
|
|
2025
Q1 | $1.23M | Sell |
10,948
-25,538
| -70% | -$2.86M | 0.39% | 111 |
|
|
2024
Q4 | $3.37M | Buy |
+36,486
| New | +$3.37M | 0.68% | 54 |
|
|
2022
Q3 | – | Sell |
-1,352
| Closed | -$83K | – | 442 |
|
|
2022
Q2 | $83K | Sell |
1,352
-2,726
| -67% | -$167K | 0.22% | 167 |
|
|
2022
Q1 | $242K | Buy |
+4,078
| New | +$242K | 0.22% | 165 |
|
|
2021
Q4 | – | Sell |
-971
| Closed | -$75K | – | 503 |
|
|
2021
Q3 | $75K | Buy |
+971
| New | +$75K | 0.09% | 285 |
|
|
2021
Q2 | – | Sell |
-3,626
| Closed | -$234K | – | 509 |
|
|
2021
Q1 | $234K | Sell |
3,626
-5,141
| -59% | -$332K | 0.26% | 143 |
|
|
2020
Q4 | $511K | Buy |
+8,767
| New | +$511K | 0.57% | 54 |
|
|
2020
Q3 | – | Sell |
-971
| Closed | -$75K | – | 517 |
|
|
2020
Q2 | $75K | Buy |
971
+749
| +337% | +$57.9K | 0.09% | 285 |
|
|
2020
Q1 | $17K | Sell |
222
-10,601
| -98% | -$812K | 0.03% | 393 |
|
|
2019
Q4 | $703K | Buy |
10,823
+731
| +7% | +$47.5K | 0.81% | 3 |
|
|
2019
Q3 | $641K | Buy |
+10,092
| New | +$641K | 0.42% | 103 |
|
|
2019
Q1 | – | Sell |
-17,984
| Closed | -$1.13M | – | 324 |
|
|
2018
Q4 | $1.13M | Buy |
+17,984
| New | +$1.13M | 0.89% | 15 |
|